GSK's Garnier says several pharma companies to fold in next few years

Share this article:
GlaxoSmithKline CEO Jean-Pierre Garnier foresees several pharmaceutical companies folding in the next few years because of increasing investments in research, he recently told German business publication Manager Magazin. “Of the 15 pharma companies that have a significant role in the world, only a handful will remain,” Garnier said in an interview published in the magazine on Friday. “Hardly any of the large companies are in the position right now to invest enough money into research,” he said. Garnier further explained in the interview that pharmaceutical companies invest too much money in advertising and marketing at the expense of more research and development, according to an Aug. 23 report on the Web site
Share this article:
You must be a registered member of MMM to post a comment.


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.